| 2025-01-30 14-48-20 | The number of Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) injected into the Annulus Fibrosus of a torn L5-S1 Intervertebral Disc (IVD) may positively correlate with overall improvement in quality of life after 4+ years |
| 2025-01-30 14-29-17 | The ideal single dose for injecting Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into the Annulus Fibrosus of a torn L5-S1 Intervertebral Disc (IVD) to improve overall quality of life after 4+ years may be 35.9 million cells |
| 2025-01-29 10-39-27 | A reduction in posterior Intervertebral Disc (IVD) bulge size by >= 25% correlates with better NPS scores compared with <25% at 6 months post-injection of an average of 23 million Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into the Nucleus Pulposus and Annulus Fibrosus of L4-L5 or L5-S1 |
| 2025-01-29 10-27-22 | 85% of patients have a decrease in posterior Intervertebral Disc (IVD) bulge size 6 months on average post-injection of an average of 23 million Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into the Nucleus Pulposus and Annulus Fibrosus of L4-L5 or L5-S1 |